Anticancer activity of Sargassum oligocystum

water extract against human cancer cell lines by ZANDI, K et al.
Abstract. – Background and Objectives:
Antitumor drug resistance and side effects of
antitumor compounds are the most common
problems in medicine. Therefore, finding new
antitumor agents with low side effects could be
interesting. This study was designed to assay
antitumor activity of the extract from brown al-
ga Sargassum oligocystum, gathered from Per-
sian Gulf seashore, against K562 and Daudi hu-
man cancer cell lines.
Materials and Methods: The research was
performed as an in vitro study. The effect of
the alga extract on proliferation of cell lines
were measured by two methods: MTT assay
and trypan blue exclusion test.
Results and Conclusion: The most effec-
tive antitumor activity has been shown at con-
centrations 500 µg/ml and 400 µg/ml of the al-
ga extract against Daudi and K562 cell lines,
respectively. The results showed that the ex-
tracts of brown alga Sargassum oligocystum
have remarkable antitumor activity against
K562 and Daudi cell lines. It is justified to be
suggested for further research such as algal
extract fractionation and purification and in vi-
vo studies in order to formulate natural com-
pounds with antitumor activities.
Key Words:
Antitumor activity, Sargassum oligocystum, Daudi,
K562, Cold water extract.
Introduction
Regarding to cancer cells resistancy to antitu-
mor drugs, finding new effective anticancer com-
pounds with less side effects has been a field of
interest for many scientists. Such studies have
been developed in recent years by nanotechnolo-
gy which represents a new area for health care
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and biotechnology1. There has been many atten-
tion to natural compounds obtained from plants
or seaweeds to investigate about their medicinal
properties. The antitumor activity was one of the
most important activities in marine drugs, and
lots of algae and their metabolites have been
showed potent cytotoxicity. These metabolites
have played an important role in leading to new
pharmaceutical compounds from algae for antitu-
mor drugs. Several studies have been done on an-
titumor activity in the east of Asia2. In one study
a research group has screened 39 algae from sea-
coast of China for their possible antitumor activi-
ties and they showed that four species of
Rhodophyta algae and three species of Phaeo-
phyta exhibited cytotoxic effects against KB and
HT-29 cancer cell lines. More than 30 com-
pounds including bromophenols, carotene and
steroids were isolated and purified from them
and their effects on cancer cell lines have been
evaluated separately2. Mechanism of antitumor
activity of Sargassum fusiforme has been investi-
gated in China3. 306 species of marine algae
from Japan coast were tested for in vitro antitu-
mor activity which four species of green algae
showed strong cytotoxicity against murine lym-
phoid leukemia L1210 cell line besides its low
cytotoxity to normal cell4. The glycoprotein de-
rived from Chlorella vulgaris showed im-
munoactive antitumor activity5. Based on investi-
gation which has performed on anticancer activi-
ty of fucoidans extracted from Sargassum poly-
cystum, Sargassum oligocystum, Sargassum mc-
clurei, Sargassum swartzii and Sargassum denti-
caprum in Vietnam, it has indicated that sulfated
compounds of them play important roles for their
antitumor activity6. 
Sargassum oligocystum is a brown alga of Sar-
gassaceae family which is widespread in the Per-
sian Gulf and has been selected in order to inves-
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Number of dead cells Number of viable cells Extract concentration (µg/mL)
1.3 × 105 9.6 × 105 0
1.4 × 105 8.5 × 105 100
1.4 × 105 8.4 × 105 200
2 × 105 7 × 105 300
1.9 × 105 5.7 × 105 400
2 × 105 4 × 105 500
Table I. Results of Viability Test for Daudi cell line after treatment with algal extract.
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equal volume of trypan blue were mixed and vi-
able and dead cells were counted by Neubauer
haemacytometer7. 
MTT Assay
MTT assay as a proper cytotoxicity test was
used in this study. Briefly, 10 µl of MTT stock
solution [5 mg/ml in phosphate buffer saline
(PBS)] was added to 90 µl medium of wells. The
microplate was incubated at 37°C for 4 hours and
then, the optical density of each well was read by
the ELISA reader (TECAN, Switzerland) in 540
nm.8
Statistical Analysis
Microsoft Excel software (2007 edition) was
used in order to calculation and drawing the cy-
totoxicity curve.
Results
Effect of Alga Extract on Daudi cell Line
The result of trypan blue exclusion test in or-
der to viable and dead cell counting after expo-
sure to different concentration of extract was
summarized in Table I. By counting viable cells
through trypan Blue exclusions test, it was
showed that Daudi cells of negative control
wells(without extract) were increased from 6×105
to 9.6×105 after 72 hr. As it showed in Table I,
100-200 µg/ml of extract didn’t show a regard-
able effect on the viable cell population. In high-
er concentrations the viable cells were decreased
which it demonstrated the cytostatic activity of
alga extract on Daudi cells. The most effective
concentration in which the number of viable cells
were decreased significantly was 500 µg/ml of
algal extract. Dead cells were presented in all
concentrations of algal extract. The most amount
of dead cell has been shown for 400 and 500
tigate about its anticancer activity against two
kinds of human tumor cell lines in this study.
Materials and Methods
Collection and Preparation of 
Alga Extract
Sargassum oligocystum, a brown alga, was
collected along the Bushehr coast of Persian Gulf
(south west of Iran) during september 2008. The
alga was rinsed with distilled water. About 10 g
of fresh algae which is equal to one gram of
dried alga was homogenized in 100 ml cold dou-
ble distilled water. The mixture was clarified by
filtration using Whatman paper No.1 filter paper.
Then the crude extract was sterilized separately
by two methods, filtering (0.22 µm) and auto-
claving. The sterilized extracts were stored in
–80°C until the date of use. 
Cell Lines
In this study, two human cancer cell lines, Hu-
man K562 (derived from human chronic myel-
ogenous leukemia cells) and Human Daudi (de-
rived from Burkitt Lymphoma cells) were used.
These cells were obtained from the Hematology
Department of Tarbiat Modarres University, Iran.
Cell Culture
K562 and Daudi cells were cultured by using
RPMI 1640 (GIBCO®) containing 10% fetal
bovine serum (GIBCO®). Cultured cells were in-
cubated at 37°C in the presence of 5% CO27.
Trypan Blue Exclusion Test
To detect the cell viability trypan blue exclu-
sion test was chosen. The cancer cells were seed-
ed at a density of 6×105 cells/well with different
concentration of extract at 37°C in the presence
of 5% CO2. After 72 hr, 20 µl of medium and
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Number of dead cells Number of viable cells Extract concentration (µg/mL)
1.3 × 105 10.2 × 105 0
1.2 × 105 9.1 × 105 100
1.2 × 105 7 × 105 200
1.5 × 105 6.9 × 105 300
1.5 × 105 4.5 × 105 400
1.6 × 105 4.6 × 105 500
Table II. Results of Viability Test for K562 cell line after treatment with algal extract.
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Figure 1. Result of MTT assay test for Daudi and K562 cell lines: 72 hours post treatment with algal extract.
µg/ml of algal extract. Dead cell increasing of
negative control wells(without extract) was al-
most equal to the wells which were treated with
100 and 200 µg/ml concentration of extract.
These results showed that there was no anti-
cancer effect up to 200 µg/ml while at concentra-
tions above the 400 µg/ml, a regardable cytotoxic
and a cytostatic activity of alga extract on Daudi
cells were observed. However, this extract had
some side effects on cells in quality such as size
and shape or they seemed somehow more wrin-
kled before adding extract.
Results of the evaluation of the algal extract
cytotoxicity against Daudi cell line through MTT
assay was shown in Figure 1. Regarding the col-
lected data it was demonstrated that 500 µg/ml of
extract showed a reasonable cytostatic effect
which was confirmed by the result of counted vi-
able cells.
Effect of Alga Extract on K562 cell Line
The result of trypan blue exclusion test in
order to viable and dead cell counting after ex-
posure to different concentration of extract
against K562 cells was summarized in Table
II. As it showed in Figure 1, the number of
negative control (without extract) K562 cells
were increased from 6.8×105 to 10.2×105 after
72 hr. Although there was a suppression effect
on cell replication for the concentration 100
µg/ml, but it couldn’t be expressed as a reason-
able anticancer activity. The effective concen-
tration was started from 300 µg/ml of algal ex-
tract concentration in which the number of vi-
able cells didn’t increase significantly. The
most effective concentration of algal extract
against  K562 cells  was 400 µg/ml.  As i t
showed in Table II, the number of viable cells
was decreased from 6.8×105 to 4.5×105. Inter-
estingly, the concentrations above 400 µg/ml
of extract didn’t exhibit the better effect
against K562 cells. 
Dead cells counting showed that the algal ex-
tract caused less amount of dead cells in compar-
ison to negative control cells.
As it shown in Figure 1 the result of MTT as-
say was confirmed that the most effective con-
centration against K562 cells is 400 µg/ml. 
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Discussion
Many marine algae have been used as food
among people in some part of the world, and cer-
tain algae have long been used in traditional Chi-
nese herbal medicine in the treatment of cancer9.
In recent years, an increasing number of studies
have shown the bioactive potential of compounds
produced by marine algae10,11.
It is a long time that human beings have
known marine algae as a rich source of pharma-
cologically active metabolites with antineoplas-
tic, antimicrobial and antiviral effects12,13. The
antitumor activity is one of the most important
activities in marine algae, and many algae have
showed cytotoxic and antitumor activities2,14.
These antitumor activities can play an important
role in leading to new pharmaceutical com-
pounds for antitumor drugs15.
Several species of algae have been found to be
sources of metabolites with antitumoral and im-
mune-stimulant activities16. Antitumor and cyto-
toxic properties of these species belong to four
structural types: polyketides, terpenes, nitrogen-
containing compounds and polysaccharides17.
Among these structural types, polysaccharides
from the Sargassum genus have antitumor activi-
ty18. In fact polysaccharides of edible algae at-
tracted extensive interest due to their biological
activities19. The anti-tumor effect of the polysac-
charide from Sargassum confusum can improve
functions of the immuno organs and enhance an-
ti-oxidative capacity in tumor-bearing mice20,
and the polysaccharide from Sargassum
fusiforme has influence on apoptosis of tumor
cells3.
Random screening is effective to have found
different marine algae with antitumor activities.
For example, Sargassum fusiforme has been in-
troduced as a selective human cancer cytotoxin21,
and significant activity against Ehrlich carcinoma
was found in the brown alga Scytosiphon lomen-
taria22. An antitumor extract from a brown ma-
rine alga Sargassum kjellmanianum has been re-
ported9.
In this study, Sargassum oligocystum has
been studied for its probable anticancer activity
against two kinds of human tumor cell lines:
Daudi and K562 cell line. Based on our data,
sterilizing of the crude extract by filtering is
better than autoclaving, so it could be conclud-
ed that some of its biological constituents are
heat sensitive. In this study, the cold water ex-
tract of Sargassum oligocystum showed the rea-
sonable activity against tumor cells replication.
The most potent antitumor activity has been
shown at concentrations 500 µg/ml and 400
µg/ml of the alga extract on Daudi and K562
cell lines, respectively. In this study the effec-
tive concentration is more than its counterpart
in other studies and it seems that the main rea-
son for this difference is because of using crude
extract in this study. Besides, regarding to the
number of K562 dead cells after exposuring to
the different concentration of algal extract we
could concluded that the cytostatic activity of
the tested extract was more regardable compar-
ing to its cytotoxic activity. 
In conclusion the Sargassum oligocystum
could be a good candidate for more studies on
other cancer cell lines and in vivo antitumor eval-
uation. It can be a new source as new marine re-
source for antitumor medicine and to demon-
strate that marine algae can be potential candi-
date sources as antitumor drugs. 
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